BridgeMD
Prevention study for Older People
Official title A Personalized Prevention Program (PPP) Based on the Comprehensive Geriatric Assessment (CGA) for the Prevention of Multidimensional Frailty Related to Non-communicable Chronic Diseases (NCDs) in Older People
ClinicalTrials.gov ID: NCT06224556
What this study is testing
What is Brief-MPI assessment (based on the Comprehensive Geriatric Assessment); Personalized Prevention Program?
Brief-MPI assessment (based on the Comprehensive Geriatric Assessment); Personalized Prevention Program is an investigational medicine, being studied as a potential treatment for older people.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Non-Communicable Diseases (NCDs) can accelerated the aging process and increase the frailty condition The Comprehensive Geriatric Assessment (CGA) is the gold standard in the geriatric clinical context Recently, in Italy the first Guidelines about the CGA in different settings for older people has been pubblicated The CGA can identify older people at high risk of frailty who can benefit from a personalized prevention program No studies has been investigated the effects of a personalized prevention program (PPP) based on the CGA in a primary care setting The main hypothesis is that the CGA assessment can result in personalized prevention programs for older subjects in primary care settings with an effect in reducing the hospitalization rate and can be related to the biological paramters in NCDs
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- 65 years old and over
- At least 1 non-communicable chronic disease
- Signed informed consent
You likely can't join if
- not willing in partecipating in the study and no signed informed consent
- \<65 years old
- without non-communicable chronic diseases
The study team makes the final eligibility decision.
Where it's taking place
- Bari, Italy
- Desenzano del Garda, Italy
- Florence, Italy
- Naples, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bari, Italy; Desenzano del Garda, Italy; Florence, Italy; Naples, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.